Clinical Trial Update: Bioflow-DAPT Study [Phase 4]

View source ↗

Summary

Phase 4 trial update for Bioflow-DAPT in coronary artery disease has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronary Artery Disease

Drugs mentioned

• Bioflow-DAPT

Snippet

Sponsor: Biotronik AG | Conditions: Coronary Artery Disease | Phase 4 | Status: COMPLETED